Sporangiomycin and micrococcin inhibit the binding of aminoacyl-transfer ribonucleic acid into the ribosomal A site in intact bacterial protoplasts. They also prevent the assembly of [ribosome-elongation factor G-guanine nucleotide] complexes in vitro and compete with [35S ]thiostrepton for ribosomal binding sites. We conclude that micrococcin and sporangiomycin block the ribosomal A site in the vicinity of the complex guanosine triphosphatase center and so resemble thiostrepton in their modes of action.
The peptide antibiotics thiostrepton, siomycin, and thiopeptin possess closely related (possibly identical) modes of action upon protein synthesis. They bind to the bacterial 50S ribosomal subunit and inhibit, in various in vitro assays, the hydrolysis of guanosine triphosphate (GTP) catalyzed by ribosomes in the presence of elongation factor G (EF G), the formation of [ribosome-EF G-guanine nucleotide] complexes and their stabilization by fusidic acid, the binding of aminoacyl-transfer ribonucleic acid (tRNA) into the ribosomal A site dependent upon elongation factor Tu (EF Tu), and the associated hydrolysis of GTP (for a review see reference 6). However, in intact bacterial protoplasts, thiostrepton specifically inhibits the binding of aminoacyf-tRNA to ribosomes (5) and does not affect the translocation reaction even though this latter process involves, in part, the EF G-dependent guanosine triphosphatase (GTPase) reaction. Subsequently, similar selectivity was reported when thiostrepton (3) or siomycin (4) was added to a cell-free system actively synthesizing protein.
These various results were rationalized and unified by the suggestion (5, 10, 12) that EF G and EF Tu may bind to ribosomes in a mutually exclusive fashion and that thiostrepton (or siomycin or thiopeptin) might, under particular conditions, bind to a single ribosomal site so as to prevent binding of either factor. According to our version, of this scheme (the single ribosomal GTPase model), thiostrepton can bind to active ribosomes only in the post-translocation state when the A site is empty, and we locate the GTPase center together with the binding sites for EF G, EF Tu, and the drug in the A site on the 50S ribosomal subunit (5) . This model is supported by numerous observations (2, 7, 11, 17, 18) and is assumed to apply to both pro-and eukaryotic ribosomes.
Here we show that two other antibiotics, sporangiomycin and micrococcin, resemble thiostrepton, siomycin, and thiopeptin in various assay systems and, moreover, that there is competition for ribosomal binding sites between radioactive thiostrepton and each of these other compounds.
MATERIALS AND METHODS
Experiments in intact cells. Bacillus megaterium strain KM was grown for several generations with [32P]phosphate to label ribosomes to a steady state and was then converted to protoplasts using lysozyme (8) . Protoplasts were incubated at 37 C for 30 s with [3H]leucine (50 Ci/mmol) to label nascent peptides before antibiotics were added (100 Ag/ml final concentration) as in Table 1 . Incubation was continued at 37 C for 2 min and then puromycin (25 gg/ml final concentration) was added for a further 60 s. Samples of protoplasts were lysed, degraded by mild treatment with ribonuclease, and analyzed on sucrose density gradients as described elsewhere (5, 8) . Nascent peptides on ribosomes were estimated from the specific radioactivity (3H in 70S monosomes/32P in total ribosomes). Polyribosomes were estimated as (32P in 70S monosomes/32P in total ribosomes).
Ribosomes. These were prepared from Escherichia coli B or B. megaterium KM which were lysed using the French pressure cell in a buffer containing: tris(hydroxymethyl)aminomethane-chloride (pH 7.6), 10 mM; magnesium acetate, 10 mM; NH4Cl, 50 mM; and dithiothreitol, 1 mM. Ribosomes were washed seven times by centrifugation through a similar buffer containing 1.0 M NH4Cl and were finally resuspended, for use, in the original buffer containing 50 mM NH4Cl.
Formation of [ribosome-EF G-guanine nucleotide] complexes. The buffer used for these experiments (Table 2 ) contained: tris(hydroxymethyl)aminomethane-chloride (10 mM), pH 7.5; magnesium ace- tate, 20 mM; NH4Cl, 10 mM; and dithiothreitol, 1 mM. Incubation 1 was as follows: E. coli ribosomes (10 pmol) were incubated with or without drug as indicated (Table 2) and fusidic acid, 2.5 mM (final concentration). Incubation 2 was terminated by the addition of 3 ml of icecold buffer containing 0.2 mM fusidic acid. Ribosomes were collected on membrane filters (Millipore HAWP filters) (0.45-pm pore size) which were washed four times with cold buffer containing 0.2 mM fusidic acid. Radioactivity retained on filters was estimated by liquid scintillation counting and was assumed to represent [ribosome-EF G-guanine nucleotide] complexes. In all cases "blank" estimations (lacking ribosomes) were used to correct experimental values which were themselves the means of dupli- Binding of radioactive thiostrepton to ribosomes. Buffer used here contained tris(hydroxymethyl)aminomethane-chloride (10 mM), pH 7.6, magnesium acetate (10 mM), NH4Cl (50 mM), and dithiothreitol (1 mM RESULTS Effects of sporangiomycin and micrococcin in intact cells. When added to intact bacterial protoplasts at concentrations well in excess of those required to stop protein synthesis, micrococcin and sporangiomycin preserved cellular polyribosomes virtually intact, but did not prevent the subsequent release by puromycin of 75 to 80% of the nascent peptide chains from those polyribosomes (Table 1) . Thiostrepton behaved similarly and, as we have previously argued (5), this pattern of behavior indicates inhibition of the binding of aminoacyl-tRNA into the ribosomal A site.
Formation of [ribosome-EF G-guanine nucleotide] complexes and the effects of antibiotics. To investigate more precisely the mechanism whereby micrococcin and sporangiomycin block the A site, their effects were compared with those of chlortetracycline (which also blocks the A site in vivo; 8) in an assay involving the formation and stabilization of [ribosome-EF G-guanine nucleotide] complexes in the presence of fusidic acid. The results are given in Table 2 together with the effects of althiomycin and thermothiocin. Again, thiostrepton, micrococcin, and sporangiomycin behaved similarly in inhibiting complex formation and differed in this respect from the other drugs Table 3 . Binding was totally prevented by prior exposure of ribosomes to sporangiomycin, siomycin, or thiopeptin and was also depressed by micrococcin, albeit to a much lesser extent. Other antibiotics tested gave very little inhibition.
DISCUSSION
We have established, in a system actively synthesizing protein, the modes of action of sporangiomycin and micrococcin and have differentiated these drugs in their action from thermothiocin and althiomycin (other sulfurcontaining polypeptides). The latter extensively inhibit the puromycin reaction in vivo (Table 1; 1) and are probably inhibitors of peptidyl transferase reactions in agreement with the previously observed action of althiomycin in vitro (14) . In contrast, sporangiomycin and micrococcin block the ribosomal A site in the vicinity of the GTPase site and the associated binding site of EF G (Table 2) . Not all drugs which block the ribosomal A site in vivo inhibit the formation of [ribosome-EF G-guanine nucleotide] complexes in vitro. Thus, chlortetracycline (8) did not inhibit complex formation (Table 2) nor did thermothiocin or althiomycin. While these results are at variance with a previous report (15) that micrococcin does not inhibit the formation of such complexes, they are entirely compatible with earlier observations concerning the action of sporangiomycin. Thus (19) , the hydrolysis of GTP by ribosomes and EF G was inhibited by sporangiomycin (the formation of complexes of the type studied here was not examined by these authors) and, in other hands (16) , the drug inhibited the EF Tu-dependent binding of aminoacyl-tRNA to ribosomes in vitro. Our demonstration ( Table 1 ) that effects of micrococcin and sporangiomycin upon this latter reaction predominate in vivo over other effects which the drugs may exert in vitro again emphasizes the similarities between the modes of action of these two compounds and that of thiostrepton.
As expected, those drugs which closely resembled thiostrepton in their modes of action competed with [35S]thiostrepton for ribosomal binding sites, although micrococcin did so relatively poorly. Although reciprocal experiments could not be carried out due to a lack of other radioactive antibiotics, it is tempting to conclude that the ribosomal binding sites for thiostrepton, siomycin, thiopeptin, sporangiomycin, and probably also micrococcin are either identical or are intimately associated in the 50S moiety of the A site. An earlier observation (9) that a 4 CUNDLIFFE AND DIXON strain of Bacillus subtilis possessing thiostrepton-resistant ribosomes was also resistant to micrococcin may well indicate that the two drugs bind to related ribosomal sites even though the ribosomes of that strain were not shown to be micrococcin resistant. Conversely, the siusceptibility towards thiostrepton of another strain which possessed micrococcin-resistant ribosomes indicates that these drugs bind to overlapping, rather than identical, sites. Since chloramphenicol and sparsomycin are thought to bind to (separate) sites in the peptidyl transferase A site recognition region (20) but do not affect the binding of thiostrepton to the GTPase center of the A site (Table 3 ), the complexity of the A site (already obvious) is emphasized.
Results similar to ours with micrococcin have recently been reported elsewhere (13) .
